Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Correction to: Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J ClinCases 2020; 8: 1361-1384. We are the team of Min Jiang and Li-Xuan Sang from the First Affiliated Hospital, China Medical University. Now we solemnly declare that the studies mentioned in this article[1] evaluated the probiotic formulation known as VSL#3 before January 31, 2016. The probiotic formulation is now commonly referred to as De Simone Formulation. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome in the United States and Vivomixx in Europe.

Cite

CITATION STYLE

APA

Sang, L. X. (2021). Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.” World Journal of Clinical Cases, 9(20), 5752–5753. https://doi.org/10.12998/wjcc.v9.i20.5752

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free